Bone Biologics Corporation (BBLG)
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.
$3.75M
Mr. Jeffrey Frelick
2.00
Burlington, MA
Mar 31, 2016
-0.12
$-17.24
8.20
11.22
0.00%
-0.39
0.00
0.69
0.00
11.22
-160.31%
-154.16%
Similar stocks (13)
Rapid Micro Biosystems, Inc.
RPID
Vivos Therapeutics, Inc.
VVOS
ReShape Lifesciences Inc.
RSLS
Talis Biomedical Corporation
TLIS
Tenon Medical, Inc.
TNON
INVO Bioscience, Inc.
INVO
Sintx Technologies, Inc.
SINT
Heart Test Laboratories, Inc.
HSCS
Bluejay Diagnostics, Inc.
BJDX
Nuwellis, Inc.
NUWE
NanoVibronix, Inc.
NAOV
Tivic Health Systems, Inc.
TIVC
Motus GI Holdings, Inc.
MOTS
Similar stocks (13)
Rapid Micro Biosystems, Inc.
RPID
Vivos Therapeutics, Inc.
VVOS
ReShape Lifesciences Inc.
RSLS
Talis Biomedical Corporation
TLIS
Tenon Medical, Inc.
TNON
INVO Bioscience, Inc.
INVO
Sintx Technologies, Inc.
SINT
Heart Test Laboratories, Inc.
HSCS
Bluejay Diagnostics, Inc.
BJDX
Nuwellis, Inc.
NUWE
NanoVibronix, Inc.
NAOV
Tivic Health Systems, Inc.
TIVC
Motus GI Holdings, Inc.
MOTS